AstraZeneca and Fudan Univ. to Collaborate on Cardiovascular Disease

AstraZeneca will collaborate with Fudan University to discover the mechanism behind leonurine, a TCM product derived from Herba Leonuri that is used to treat heart disease, ischemic stroke and atherosclerosis. AstraZeneca will underwrite the cost of two years of research with the hope of discovering a new treatment for the diseases. More details.... Stock Symbol: (NYSE: AZN) Share this with colleagues: // <![CDATA[ var switchTo5x=true; // <![CDATA[ stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});